UroGen's Lead Product Data Back Barrett's Interest

 
• By John Davis

UroGen's reverse thermal gel formulation of mitomycin produced a high rate of complete responses in patients with urothelial cancer; developing a commercialization strategy for the product will benefit from the experience of the company's new CEO.  

HumanBladder
It is difficult to resect tumors located in the pelvic region • Source: Shutterstock

More from Anticancer

More from Therapy Areas